<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/National_Institutes_of_Health/2006-12-20/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Tue, Dec 2 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Tue, Dec 2 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Government-Owned Inventions; Availability for Licensing ]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-E6-21665</link>
  <description><![CDATA[ The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federallyfunded research and development. Foreign patent 
applications are filed on selected inventions to extend market coverage 
for companies and may also be available for licensing.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-E6-21665</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Government-Owned Inventions; Availability for Licensing ]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-E6-21666</link>
  <description><![CDATA[ The inventions listed below are owned by an agency of the U.S. 
Government and are available for licensing in the U.S. in accordance 
with 35 U.S.C. 207 to achieve expeditious commercialization of results 
of federallyfunded research and development. Foreign patent 
applications are filed on selected inventions to extend market coverage 
for companies and may also be available for licensing.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-E6-21666</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Center for Complementary & Alternative Medicine; Notice  of Meeting]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-06-9773</link>
  <description><![CDATA[
</p><p>    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM)  meeting.</p><p>    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person  listed below in advance of the meeting.</p><p>    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and/or contract 
proposals and the discussion could disclose confidential trade secrets 
or commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
c<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-06-9773</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Institute of Allergy and Infectious Diseases; Notice of  Meetings]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-06-9774</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of 
the National Advisory Allergy and Infectious Diseases Council.
</p><p>    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person  listed below in advance of the meeting.</p><p>    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
</p><p>    Name of Commit<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-06-9774</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  National Institute of Allergy and Infectious Diseases; Notice of  Meetings]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-06-9775</link>
  <description><![CDATA[
</p><p>    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meetings  of the AIDS Research Advisory Committee, NIAID.</p><p>    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in  advance of the meeting.</p><p>    Name of Committee: AIDS Research Advisory Committee, NIAID. </p><p>    Date: January 29, 2007.<br/> </p><p>    Time: 1 p.m. to 5 p.m.</p><p>    Agenda: Report from the Division Director and other staff.
</p><p>    Place: National Institutes of Health, Natcher Building, 45  Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.</p><p>    Contact Person: Rona L. Siskind, Executive Secretary, AIDS 
Research Advisory Committee, Division of AIDS, NIAID/NIH, 6700B 
Rockledge Drive, Room 4139, Bethesda, MD 208927601. 3014353732.
</p><p>    Name of Committee: AIDS Researc<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-06-9775</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Prospective Grant of Exclusive License: Immunoconjugates Having  High Binding Affinity]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-20-E6-21667</link>
  <description><![CDATA[ This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i), that the National Institutes of Health, Department 
of Health and Human Services, is contemplating the grant of an 
exclusive patent license to practice the inventions embodied in U.S. 
Patent No. 7,081,518, issued July 25, 2006, entitled ``AntiMesothelin 
Antibodies Having HighAffinity Binding'' [E1391999/0US07]; 
European Patent Application No. 00937925.6, filed May 26, 2000, 
entitled ``Immunoconjugates Having High Binding Affinity'' [E1391999/
0EP04]; Japanese Patent Application No. 2001500670, filed May 26, 
2000, entitled ``Immunoconjugates Having High Binding Affinity'' [E
1391999/0JP05]; Mexican Patent Application No. PA/a/2001/01195, 
filed May 26, 2000, entitled ``Immunoconjugates Having High Binding 
Affinity'' [E1391999/0MX06]; and Canadian Patent Application No. 
2374398, filed May 26, 2000, entitled ``Immunoconjugates Having High  Binding Affinity'' [E1391999/0CA03] to Cambridge Antibody <br/>
Technology, Ltd., which <script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-20-E6-21667</guid>
  <pubDate>Wed, Dec 20 2006 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

